Page last updated: 2024-08-21

pyrazines and Testicular Diseases

pyrazines has been researched along with Testicular Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eriksson, E; Hou, M; Jahnukainen, K; Meinhardt, A; Sävendahl, L; Söder, O; Svechnikov, K1
Cai, G; Fu, J; Li, W; Xie, N; Zhang, S; Zhao, J1
De Raeve, H; Lambert, J; Rombouts, S; Schroyens, W; Van de Velde, A; Van de Voorde, K; Van Regenmortel, N1

Other Studies

3 other study(ies) available for pyrazines and Testicular Diseases

ArticleYear
Bortezomib treatment causes long-term testicular dysfunction in young male mice.
    Molecular cancer, 2014, Jun-20, Volume: 13

    Topics: Animals; Boronic Acids; Bortezomib; Follicle Stimulating Hormone; Humans; Male; Mice; Neoplasms; Proteasome Inhibitors; Pyrazines; Spermatogenesis; Testicular Diseases; Testis; Testosterone

2014
The proteasome inhibitor bortezomib induces testicular toxicity by upregulation of oxidative stress, AMP-activated protein kinase (AMPK) activation and deregulation of germ cell development in adult murine testis.
    Toxicology and applied pharmacology, 2015, Jun-01, Volume: 285, Issue:2

    Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Enzyme Activation; Fertility; Germ Cells; Gonadal Steroid Hormones; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Proteasome Endopeptidase Complex; Pyrazines; Sertoli Cells; Spermatogenesis; Testicular Diseases; Testis; Up-Regulation

2015
Bortezomib-induced Sweet's syndrome.
    Haematologica, 2005, Volume: 90, Issue:12 Suppl

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Drug Administration Schedule; Erectile Dysfunction; Humans; Immunosuppressive Agents; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Pain; Peripheral Nervous System Diseases; Prednisolone; Protease Inhibitors; Pyrazines; Recurrence; Sleep Initiation and Maintenance Disorders; Sweet Syndrome; Testicular Diseases

2005